![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Frontiers | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors Frontiers | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors](https://www.frontiersin.org/files/Articles/694441/fonc-11-694441-HTML-r1/image_m/fonc-11-694441-t001.jpg)
Frontiers | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![Blood ovarian cancer marker test. CA 125. Uterus, ovary with a tumor. Vector medical illustration. White background. Stock-Vektorgrafik | Adobe Stock Blood ovarian cancer marker test. CA 125. Uterus, ovary with a tumor. Vector medical illustration. White background. Stock-Vektorgrafik | Adobe Stock](https://as2.ftcdn.net/v2/jpg/02/57/87/91/1000_F_257879110_YXeX5zXJVj9dHFHjP6uDWg7AJPUrKkkj.jpg)